AI stocks are starting to heat up again 🔥

No news is great news for this tiny company                                                                                                                                                                                                                                                                                                                                                                                                                 January 05, 2024 Sponsored by Happy Friday, 360! TWO SWEET INVITES today! 1) Kenny Glick is live again for complimentary training at 10am EST in the [Warlock Room]( 🧌 – come learn about the power of VWAP indicators! 2) Join Jeff Bishop for a 30-minute POWER LUNCH🌮 as he looks at awesome trading ideas going into next week: [Market Masters Chat Room]([at 1 PM ET](. FOCUS LIST🔎 AIMD - Up over 150% in pre-market on no identifiable news  SGD - Up over 60% in pre after announcing update for acquisition of XENE Real Estate AI software yesterday DRMA - Up over 50% in pre after the issuance of a new patent in Japan for its treatment of Hyperhidrosis *sponsored by RadAI This AI Startup Investment is Winning RAD AI has developed technology that transforms the $633B MarTech industry. Its award-winning AI tells brands who their customer is and how to best create content for them. [Investors are taking notice, here’s why:Â]( 1) $27M raised from 6,000+ investors, including VCs, execs at Google and Amazon. Backed by Adobe Fund for Design. 2) Dubbed “essential AI” for brands looking to attract new audiences and boost ROI. 3) 3X revenue growth, clients include Hasbro, Sweetgreen, MGM and more. [Invest Here]( Disclosure: This is a paid advertisement for RAD AI’s Regulation CF offering. Please read the offering circular at [invest.radintel.ai]( *Sponsored content, please see all disclosures below HOTLIST🔥 AIMD - Up over 150% in pre-market on no identifiable news  Ainos (AIMD) is a healthcare company that engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform and is also involved in the development of AI Nose technology, attempting to accelerate the digitalization of smell. Despite no identifiable news this morning, the stock is trading up over 100% in pre-market, however we are seeing some renewed interest in AI related stocks with the sector starting to slowly heat up again. $4.20 was resistance that began to act as support in the pre-market. Above it, targets to the upside are $4.50 and then the pre-market high at $4.82. Beyond that, $5, $5.50, $6 and $7 come into play. Below $4.20, there is potential support at $3.60, $3.30, $2.80 and a gap to fill at $1.73. SGD - Up over 60% in pre after announcing update for acquisition of XENE Real Estate AI software yesterday Safe and Green Development Corporation (SGD) operates as a real estate development company. It focuses on building single or multifamily projects. Yesterday in the pre-market, the company [provided an update]( on its letter of intent (LOI) for its acquisition of XENE Real Estate AI software. SGD [stated]( that “After conducting initial due diligence, the Company has negotiated a complete acquisition of Xene Platform along with its parent company MWH. The company will look to complete the acquisition by the end of the first quarter subject to final approval by the Board of Directors and execution of definitive documents.” After a small pop yesterday before closing lower, this previous runner from November has traded up over 60% in the pre-market this morning. $2 has acted as a support level in the pre-market and will be an important level to watch. Above it, targets to the upside are $2.20, $2.32 and then the pre-market high at $2.48. Beyond that, $3, $3.80 and $5 come into play. Below $2, potential targets to the downside are $1.80, $1.60 and then a gap fill at $1.36. DRMA - Up over 50% in pre after the issuance of a new patent in Japan for its treatment of Hyperhidrosis Dermata Therapeutics (DRMA) is a clinical-stage medical dermatology company that focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. In the after-hours yesterday, the [company announced]( that it had expanded its global intellectual patent portfolio with the issuance of a Japanese patent for its DMT410 program for the treatment of Hypehidrosis. DRMA also [noted](: “[I]t is currently discussing partnership opportunities to advance development of DMT410.” The stock traded up over 50% in pre-market this morning after the Press Release. The $1 area should be an important pivot level this morning, having shown some support so far this morning. Above it, targets to the upside are $1.10, $1.20, $1.40 and then the pre-market high at $1.44. Beyond that $2, and $2.50 come into play. Below $1, there is potential support at $0.95, $0.90, $0.80 and then a gap fill at $0.6099. MARKET NEWS 📰 Questions or concerns about our products? Email [Support@360wallstreet.io]( © Copyright 2022, RagingBull DISCLAIMER To more fully understand any Ragingbull.com, LLC ("RagingBull") subscription, website, application or other service ("Services"), please review our full disclaimer located at [( FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any RagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision. *ISSUER-PAID ADVERTISEMENT: This Issuer has previously paid RagingBull.com, LLC (“Raging Bull”) forty seven thousand five hundred dollars to run advertisements enhancing public awareness of the company. Raging Bull is currently invested in this company. RagingBull is currently an Affiliate for RadAI. If you purchase anything through a link in this email other than RagingBull services, you should assume that we have an affiliate relationship with the company providing the product or service that you purchase, and that we will be paid in some way. We recommend that you do your own independent research before purchasing anything. We believe in the companies we form affiliate relationships with, but please don’t spend any money on these products or services unless you believe they will help you achieve your goals. RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers' trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment. RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. Employees, owners, and other service providers of https:// ragingbull. com or RagingBull.com LLC are paid in whole or in part by commission based on their sales of Services to subscribers. *Sponsored Content: If you purchase anything through a link in this email other than RagingBull services, you should assume that we have an affiliate relationship with the company providing the product or service that you purchase, and that we will be paid in some way. We recommend that you do your own independent research before purchasing anything. We believe in the companies we form affiliate relationships with, but please don’t spend any money on these products or services unless you believe they will help you achieve your goals. RagingBull.com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements. In the event that any suit or action is instituted as a result of doing business with RagingBull. com, LLC and/or its affiliates or if any suit or action is necessary to enforce or interpret these Terms of Service, RagingBull. com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements in addition to any other relief to which it may be entitled. WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services except possibly by advertisers in this email. However, Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication [tw]( Update your email preferences or unsubscribe [here]( © 2024 360wallstreet 62 Calef Hwy. #233 Lee, NH 03861, United States of America